Skip to content

Top gainers Top losers Most active Market sectors Heatmap Treasury rates

Earnings calendar IPO calendar Ex-dividend calendar Economic calendar

Congress trades Insider trades Analyst upgrades & downgrades

Screener Compare Backtester

Valuation Fundamentals

Watchlist Portfolio

⌕/

Markets

Stocks Gainers Losers Most active Market sectors Heatmap Earnings calendar Congress trades Insider trades Analyst upgrades/downgrades IPO calendar Ex-dividend calendar

Tools

Screener Compare stocks Returns backtester Portfolio tracker Watchlist Embeddable widget

Metrics

Valuation Fundamentals

Popular lists

Best dividend stocks Best value stocks Largest companies Lowest P/E stocks

Collections

All lists & collections US stocks Japanese stocks Chinese stocks Hong Kong stocks South Korean stocks Taiwanese stocks Canadian stocks UK stocks European stocks Magnificent 7 AI stocks Semiconductor stocks

Compare

Compare stocks Finviz alternative Koyfin alternative TradingView alternative StockAnalysis alternative

Learn

Investing glossary Help & guide

StockMarketCapDocs Token Terms PrivacyData for information only, not investment advice.

◆

Exelixis, Inc. (EXEL) News - StockMarketCap

Stocks›Exelixis, Inc.☆

● At closeAs of Jul 2, 2026

Exelixis, Inc.

EXEL✓

HealthcareBiotechnologyNASDAQ

$55.85+3.50%

$14.04BMarket cap

17.50xP/E ratio

2.36MVolume (24h)

Overview Forecast Valuation Financials Technical Dividends Smart money News

Price

$55.85

$1.89 (+3.50%) · 24h

Key metrics

Market cap$14.04B+8.21%

Enterprise value$13.66B

Volume (24h)2.36M

P/E ratio (TTM)17.50x

P/S ratio (TTM)5.78x

Dividend yield0.00%

Shares outstanding251.36M

Trading range

Previous close$53.96

Day range$54.10 - $56.21

52-week range$33.76 - $55.91

Exelixis, Inc. (EXEL) operates in the Biotechnology industry within the Healthcare sector, listed on NASDAQ.

Similar stocks

Eli Lilly and Company+1.57%

Johnson & Johnson+3.57%

AbbVie Inc.+3.99%

UnitedHealth Group Incorporated-0.28%

Roche Holding AG+3.89%

Merck & Co., Inc.+3.31%

Latest news